The global orphan drug market size stood at US$ 216.66 billion in 2025, grew to US$ billion in 2026, and is forecast to reach ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
There are times when the often unfairly criticized Congressional Budget Office (CBO) gets in its own way in preserving its credibility. The CBO shot itself in the foot with the revision estimating ...
The world’s deadliest infectious disease urgently requires new and effective antibiotics. Researchers have created a promising new compound that may mark a major step forward in the global effort to ...
A new compound called CMX410 may change the fight against tuberculosis. It targets a weak point in the bacteria’s defenses, ...
"The papers and data we've presented at the November IEEE conference show how Verseon's advances in AI produce superior results in life-science applications," said Verseon's Head of AI Ed Ratner. "Our ...
Pharmaceutical Technology on MSN
CPHI 2025: directing AI-driven innovation to harness Europe’s data edge
The biopharma industry of Europe can use AI to leverage its vast stores of health data to address key challenges.
Malaria is a lethal parasitic infectious disease caused by Plasmodium protozoa. Despite significant advancements in ...
Packaging Gateway on MSN
Innovations in injectable drug packaging
Innovations in injectable drug packaging are transforming how medications are delivered, combining safety, convenience, and ...
Massimo Radaelli, PhD, is a European pharmaceutical industry leader and entrepreneur who has devoted more than 30 years to the innovation of therapies to treat rare diseases. He is President and CEO ...
Your editorial on “Why Vinay Prasad Had to Go at FDA” should be a wake-up call for anyone who cares whether federal bureaucrats get to decide if promising new medicines are available to desperately ...
Some of the most ambitious cancer science is happening in a disease few outside of oncology can name, and it’s revealing a future where cancer is no longer a death sentence. Multiple myeloma (MM) is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results